## GEORGE HUTTON

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Neurology  
Address| 7200 CAMBRIDGE  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=MaMl9XHILqv3RYKj5X%2fX&rnd=5cfebd35-b85a-4887-948b-afbfcf7ab499)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=267030)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=267030&cachekey=e6b0f9b8-322c-40ca-925f-6f600ce8d3b4)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Rempe T, Rodriguez E, Elfasi A, Alkabie S, Perero MM, Castrodad-Molina R, [Cuascut FX](https://profiles.viictr.org/profile/24845174), **Hutton GJ** , Kinkel R, Graves J. Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2024 Jul; 87:105672. PMID: [38749350](//www.ncbi.nlm.nih.gov/pubmed/38749350).

Citations:  Fields:

Neu Neurology

Translation:Humans

  2. Earla JR, Li J, **Hutton GJ** , Bentley JP, [Aparasu RR](https://profiles.viictr.org/profile/268977). Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis. Mult Scler Relat Disord. 2024 May; 85:105539. PMID: [38574721](//www.ncbi.nlm.nih.gov/pubmed/38574721).

Citations:  Fields:

Neu Neurology

Translation:Humans

  3. Li J, Huang Y, **Hutton GJ** , [Aparasu RR](https://profiles.viictr.org/profile/268977). Assessing treatment switch among patients with multiple sclerosis: A machine learning approach. Explor Res Clin Soc Pharm. 2023 Sep; 11:100307. PMID: [37554927](//www.ncbi.nlm.nih.gov/pubmed/37554927); PMCID: [PMC10405092](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10405092).

Citations:

  4. Earla JR, Li J, **Hutton GJ** , [Johnson ML](https://profiles.viictr.org/profile/268978), [Aparasu RR](https://profiles.viictr.org/profile/268977). Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2023 06; 43(6):473-484. PMID: [37157135](//www.ncbi.nlm.nih.gov/pubmed/37157135).

Citations:  Fields:

Dru Drug Therapy

Translation:Humans

  5. Moore MZ, P?rez CA, **Hutton GJ** , [Patel H](https://profiles.viictr.org/profile/41761845), [Cuascut FX](https://profiles.viictr.org/profile/24845174). Health Disparities in Multiple Sclerosis among Hispanic and Black Populations in the United States. Biomedicines. 2023 Apr 20; 11(4). PMID: [37189845](//www.ncbi.nlm.nih.gov/pubmed/37189845); PMCID: [PMC10135818](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10135818).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37189845/citedby/)

  6. P?rez CA, [Cuascut FX](https://profiles.viictr.org/profile/24845174), **Hutton GJ**. Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update. Neurol Clin. 2023 02; 41(1):87-106. PMID: [36400561](//www.ncbi.nlm.nih.gov/pubmed/36400561).

Citations:  Fields:

Neu Neurology

Translation:Humans

  7. Li J, Zakeri M, **Hutton GJ** , [Aparasu RR](https://profiles.viictr.org/profile/268977). Health-related quality of life of patients with multiple sclerosis: Analysis of ten years of national data. Mult Scler Relat Disord. 2022 Oct; 66:104019. PMID: [35839614](//www.ncbi.nlm.nih.gov/pubmed/35839614).

Citations:  Fields:

Neu Neurology

  8. Li J, Chikermane SG, Earla JR, **Hutton GJ** , [Aparasu RR](https://profiles.viictr.org/profile/268977). FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS. Mult Scler Relat Disord. 2022 Apr; 60:103703. PMID: [35278846](//www.ncbi.nlm.nih.gov/pubmed/35278846).

Citations:  Fields:

Neu Neurology

Translation:Humans

  9. Choudhury NA, Castrodad-Molina RM, **Hutton GJ** , [Cuascut FX](https://profiles.viictr.org/profile/24845174). Elsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse. Mult Scler Relat Disord. 2022 Feb; 58:103498. PMID: [35007821](//www.ncbi.nlm.nih.gov/pubmed/35007821).

Citations:  Fields:

Neu Neurology

Translation:Humans

  10. Alkabie S, [Tanweer O](https://profiles.viictr.org/profile/34089583), **Hutton GJ** , [Cuascut FX](https://profiles.viictr.org/profile/24845174). Clinical Reasoning: A 57-Year-Old Man With Stepwise Progressive Paraparesis, Sensory Loss, Urinary Retention, and Constipation. Neurology. 2022 02 01; 98(5):e555-e560. PMID: [34799458](//www.ncbi.nlm.nih.gov/pubmed/34799458).

Citations:  Fields:

Neu Neurology

Translation:Humans

  11. Talwar A, Earla JR, **Hutton GJ** , [Aparasu RR](https://profiles.viictr.org/profile/268977). Prescribing of disease modifying agents in older adults with multiple sclerosis. Mult Scler Relat Disord. 2022 Jan; 57:103308. PMID: [35158421](//www.ncbi.nlm.nih.gov/pubmed/35158421).

Citations:  Fields:

Neu Neurology

Translation:Humans

  12. Lee H, Nakamura K, Narayanan S, Brown RA, Nash RA, Griffith LM, Steinmiller KC, Devine SM, **Hutton GJ** , [Popat U](https://profiles.viictr.org/profile/12583693), Racke MK, Georges GE, Bowen JD, Arnold DL. Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2021 Sep; 54:103149. PMID: [34284316](//www.ncbi.nlm.nih.gov/pubmed/34284316).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34284316/citedby/) Fields:

Neu Neurology

Translation:Humans

  13. [Cuascut FX](https://profiles.viictr.org/profile/24845174), Alkabie S, **Hutton GJ**. Fingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis. Mult Scler Relat Disord. 2021 Aug; 53:103072. PMID: [34139459](//www.ncbi.nlm.nih.gov/pubmed/34139459).

Citations:  Fields:

Neu Neurology

Translation:Humans

  14. Earla JR, **Hutton GJ** , Thornton JD, Chen H, [Johnson ML](https://profiles.viictr.org/profile/268978), [Aparasu RR](https://profiles.viictr.org/profile/268977). Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis. Explor Res Clin Soc Pharm. 2021 Jun; 2:100021. PMID: [35481133](//www.ncbi.nlm.nih.gov/pubmed/35481133); PMCID: [PMC9031432](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9031432).

Citations:

  15. Earla JR, **Hutton GJ** , Thornton DJ, Chen H, [Johnson ML](https://profiles.viictr.org/profile/268978), [Aparasu RR](https://profiles.viictr.org/profile/268977). Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450. PMID: [33641232](//www.ncbi.nlm.nih.gov/pubmed/33641232).

Citations:  Fields:

Dru Drug Therapy

Translation:Humans

  16. Alkabie S, Castrodad-Molina R, Heck KA, [Mandel J](https://profiles.viictr.org/profile/8183294), **Hutton GJ**. The concurrence of multiple sclerosis and glioblastoma. Mult Scler Relat Disord. 2021 May; 50:102877. PMID: [33711579](//www.ncbi.nlm.nih.gov/pubmed/33711579).

Citations:  Fields:

Neu Neurology

Translation:HumansCells

  17. Mercado V, Dongarwar D, [Fisher K](https://profiles.viictr.org/profile/37935574), Salihu HM, **Hutton GJ** , [Cuascut FX](https://profiles.viictr.org/profile/24845174). Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis. Biomedicines. 2020 Nov 25; 8(12). PMID: [33255552](//www.ncbi.nlm.nih.gov/pubmed/33255552); PMCID: [PMC7760789](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7760789).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33255552/citedby/)

  18. Earla JR, **Hutton GJ** , Thornton JD, Chen H, [Johnson ML](https://profiles.viictr.org/profile/268978), [Aparasu RR](https://profiles.viictr.org/profile/268977). Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient Prefer Adherence. 2020; 14:2187-2199. PMID: [33177813](//www.ncbi.nlm.nih.gov/pubmed/33177813); PMCID: [PMC7649232](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7649232).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33177813/citedby/)

  19. Earla JR, **Hutton GJ** , Thornton JD, [Aparasu RR](https://profiles.viictr.org/profile/268977). Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334. PMID: [32629400](//www.ncbi.nlm.nih.gov/pubmed/32629400).

Citations:  Fields:

Neu Neurology

Translation:Humans

  20. Earla JR, Thornton JD, **Hutton GJ** , [Aparasu RR](https://profiles.viictr.org/profile/268977). Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749. PMID: [32463779](//www.ncbi.nlm.nih.gov/pubmed/32463779); PMCID: [PMC10391019](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10391019).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32463779/citedby/) Fields:

Pha Pharmacy

Translation:Humans

  21. Oh J, Achiron A, Chambers C, Derwenskus J, Devonshire V, Hellwig K, **Hutton GJ** , McCombe P, Moore M, Rog D, Schneider JR, Vincent SG, Chung L, Daizadeh N, Mitchell C, Compston DAS, CAMMS223, CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators, Celius EG, Simm RF, Sousa L. Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Mult Scler Relat Disord. 2020 Aug; 43:102146. PMID: [32498033](//www.ncbi.nlm.nih.gov/pubmed/32498033).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32498033/citedby/) Fields:

Neu Neurology

Translation:HumansCTClinical Trials

  22. [Fisher KS](https://profiles.viictr.org/profile/37935574), [Cuascut FX](https://profiles.viictr.org/profile/24845174), [Rivera VM](https://profiles.viictr.org/profile/268173), **Hutton GJ**. Current Advances in Pediatric Onset Multiple Sclerosis. Biomedicines. 2020 Mar 28; 8(4). PMID: [32231060](//www.ncbi.nlm.nih.gov/pubmed/32231060); PMCID: [PMC7235875](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7235875).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32231060/citedby/)

  23. Earla JR, Paranjpe R, Kachru N, **Hutton GJ** , [Aparasu RR](https://profiles.viictr.org/profile/268977). Use of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data. Res Social Adm Pharm. 2020 Dec; 16(12):1670-1676. PMID: [32171597](//www.ncbi.nlm.nih.gov/pubmed/32171597).

Citations:  Fields:

Pha Pharmacy

Translation:Humans

  24. Wang KY, [Carlton J](https://profiles.viictr.org/profile/29494089), Guffey D, **Hutton GJ** , [Moron FE](https://profiles.viictr.org/profile/270219). Histogram analysis of apparent diffusion coefficient and fluid-attenuated inversion recovery in discriminating between enhancing and nonenhancing lesions in multiple sclerosis. Clin Imaging. 2020 Jan; 59(1):13-20. PMID: [31715512](//www.ncbi.nlm.nih.gov/pubmed/31715512).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31715512/citedby/) Fields:

Dia Diagnostic Imaging

Translation:Humans

  25. [Cuascut FX](https://profiles.viictr.org/profile/24845174), **Hutton GJ**. Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives. Biomedicines. 2019 Mar 30; 7(2). PMID: [30935074](//www.ncbi.nlm.nih.gov/pubmed/30935074); PMCID: [PMC6631931](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6631931).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30935074/citedby/)

  26. Yeo CJJ, **Hutton GJ** , Fung SH. Advanced neuroimaging in Balo's concentric sclerosis: MRI, MRS, DTI, and ASL perfusion imaging over 1 year. Radiol Case Rep. 2018 Oct; 13(5):1030-1035. PMID: [30228838](//www.ncbi.nlm.nih.gov/pubmed/30228838); PMCID: [PMC6137900](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6137900).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30228838/citedby/)

  27. Nash RA, **Hutton GJ** , Racke MK, [Popat U](https://profiles.viictr.org/profile/12583693), Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD. High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology. 2017 Feb 28; 88(9):842-852. PMID: [28148635](//www.ncbi.nlm.nih.gov/pubmed/28148635); PMCID: [PMC5331868](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28148635/citedby/) Fields:

Neu Neurology

Translation:HumansCTClinical Trials

  28. [Mandel JJ](https://profiles.viictr.org/profile/8183294), Goethe EA, [Patel AJ](https://profiles.viictr.org/profile/7520391), Heck K, **Hutton GJ**. Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis. J Neurol Sci. 2016 Oct 15; 369:51-52. PMID: [27653865](//www.ncbi.nlm.nih.gov/pubmed/27653865).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27653865/citedby/) Fields:

Neu Neurology

Translation:Humans

  29. Yapundich R, Applebee A, Bethoux F, Goldman MD, **Hutton GJ** , Mass M, Pardo G, Klingler M, Henney HR, Blight AR, Carrazana EJ. Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial. Int J MS Care. 2015 May-Jun; 17(3):138-45. PMID: [26052259](//www.ncbi.nlm.nih.gov/pubmed/26052259); PMCID: [PMC4455866](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4455866).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26052259/citedby/)

  30. Nash RA, **Hutton GJ** , Racke MK, [Popat U](https://profiles.viictr.org/profile/12583693), Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD, St?ve O. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report. JAMA Neurol. 2015 Feb; 72(2):159-69. PMID: [25546364](//www.ncbi.nlm.nih.gov/pubmed/25546364); PMCID: [PMC5261862](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5261862).

Citations:
[55](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25546364/citedby/) Fields:

Neu Neurology

Translation:HumansCTClinical Trials

  31. [Schurmann P](https://profiles.viictr.org/profile/3009932), Basra S, Awar OG, Aguilar D, Basant A, Dragan E, **Hutton GJ** , [Birnbaum Y](https://profiles.viictr.org/profile/265899). Abnormal rhythms in patients without known cardiac disease after a first dose of fingolimod. Mult Scler Relat Disord. 2014 May; 3(3):408-12. PMID: [25876482](//www.ncbi.nlm.nih.gov/pubmed/25876482).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25876482/citedby/) Fields:

Neu Neurology

  32. Chen M, Chen G, Deng S, Liu X, **Hutton GJ** , Hong J. IFN-? induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis. J Neuroimmunol. 2012 Jan 18; 242(1-2):39-46. PMID: [22112394](//www.ncbi.nlm.nih.gov/pubmed/22112394).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22112394/citedby/) Fields:

All Allergy and ImmunologyNeu Neurology

Translation:HumansAnimalsCells

  33. Stosic M, De Jesus P, McCarthy J, **Hutton G** , [Rivera V](https://profiles.viictr.org/profile/268173). Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology. 2011 Aug 02; 77(5):505-7. PMID: [21775738](//www.ncbi.nlm.nih.gov/pubmed/21775738).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21775738/citedby/) Fields:

Neu Neurology

Translation:Humans

  34. Avila-Ornelas J, Avila M, Stosic M, Robles L, Prieto PG, **Hutton GJ** , [Rivera VM](https://profiles.viictr.org/profile/268173). The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis. Int J MS Care. 2011; 13(2):91-3. PMID: [24453710](//www.ncbi.nlm.nih.gov/pubmed/24453710); PMCID: [PMC3882955](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3882955).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24453710/citedby/)

  35. Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, Montague PR, **Hutton GJ**. Functional brain network changes associated with maintenance of cognitive function in multiple sclerosis. Front Hum Neurosci. 2010; 4:219. PMID: [21152340](//www.ncbi.nlm.nih.gov/pubmed/21152340); PMCID: [PMC2996259](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2996259).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21152340/citedby/)

  36. Hong J, **Hutton GJ**. Regulatory effects of interferon-? on osteopontin and interleukin-17 expression in multiple sclerosis. J Interferon Cytokine Res. 2010 Oct; 30(10):751-7. PMID: [20874252](//www.ncbi.nlm.nih.gov/pubmed/20874252).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20874252/citedby/) Fields:

All Allergy and Immunology

Translation:HumansCells

  37. Cohen JA, Imrey PB, Calabresi PA, Edwards KR, Eickenhorst T, Felton WL, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, **Hutton GJ** , Mandell BF, Scott TF, Zhang H, Apperson-Hansen C, Beck GJ, Houghtaling PL, Karafa MT, Stadtler M, ACT Investigators. Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS. Neurology. 2009 Feb 10; 72(6):535-41. PMID: [19204263](//www.ncbi.nlm.nih.gov/pubmed/19204263).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19204263/citedby/) Fields:

Neu Neurology

Translation:Humans

  38. **Hutton GJ** , Avila M, Suarez GA. Pneumocephalus after an epidural steroid injection. Clin Neurol Neurosurg. 2009 Apr; 111(3):309-10. PMID: [19036497](//www.ncbi.nlm.nih.gov/pubmed/19036497).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19036497/citedby/) Fields:

Neu NeurologyNeu Neurosurgery

Translation:Humans

  39. [Lotze TE](https://profiles.viictr.org/profile/267050), Northrop JL, **Hutton GJ** , Ross B, Schiffman JS, Hunter JV. Spectrum of pediatric neuromyelitis optica. Pediatrics. 2008 Nov; 122(5):e1039-47. PMID: [18838462](//www.ncbi.nlm.nih.gov/pubmed/18838462).

Citations:
[32](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18838462/citedby/) Fields:

Ped Pediatrics

Translation:Humans

  40. **Hutton GJ** , Su?rez Zambrano GA. Heart-shaped lesion secondary to neurosarcoidosis. Arch Neurol. 2008 Oct; 65(10):1388-9. PMID: [18852359](//www.ncbi.nlm.nih.gov/pubmed/18852359).

Citations:  Fields:

Neu Neurology

Translation:Humans

  41. Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, **Hutton GJ** , Imrey PB, Ivancic DM, Mandell BF, Perryman JE, Scott TF, Skaramagas TT, Zhang H, ACT Investigators. Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. Mult Scler. 2008 Apr; 14(3):370-82. PMID: [18208877](//www.ncbi.nlm.nih.gov/pubmed/18208877).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18208877/citedby/) Fields:

Neu Neurology

Translation:HumansCTClinical Trials

  42. Nash RA, Stuve O, Bowen JD, Frohman EM, Griffith LM, **Hutton GJ** , Kraft GH, [Popat U](https://profiles.viictr.org/profile/12583693), Racke MK, Muraro PA. Autologous HSCT for advanced MS: is the glass half-empty or really half-full? Brain. 2008 Feb; 131(Pt 2):e89; author reply e90. PMID: [17908695](//www.ncbi.nlm.nih.gov/pubmed/17908695).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17908695/citedby/) Fields:

Bra BrainNeu Neurology

Translation:HumansCells

  43. Vu T, [Carrum G](https://profiles.viictr.org/profile/269657), **Hutton G** , [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, [Kamble R](https://profiles.viictr.org/profile/265557). Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(11):705-9. PMID: [17401392](//www.ncbi.nlm.nih.gov/pubmed/17401392).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17401392/citedby/) Fields:

Tra Transplantation

Translation:HumansCells

  44. Zhang J, **Hutton G**. Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis. Annu Rev Med. 2005; 56:273-302. PMID: [15660513](//www.ncbi.nlm.nih.gov/pubmed/15660513).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15660513/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  45. Bakshi R, **Hutton GJ** , Miller JR, Radue EW. The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis. Neurology. 2004 Dec 14; 63(11 Suppl 5):S3-11. PMID: [15596734](//www.ncbi.nlm.nih.gov/pubmed/15596734).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15596734/citedby/) Fields:

Neu Neurology

Translation:Humans

  46. Zang YC, Skinner SM, Robinson RR, Li S, [Rivera VM](https://profiles.viictr.org/profile/268173), **Hutton GJ** , Zhang JZ. Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis. Mult Scler. 2004 Oct; 10(5):499-506. PMID: [15471364](//www.ncbi.nlm.nih.gov/pubmed/15471364).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15471364/citedby/) Fields:

Neu Neurology

Translation:HumansCells

  47. Wyss K, **Hutton G** , N'Diekhor Y. Costs attributable to AIDS at household level in Chad. AIDS Care. 2004 Oct; 16(7):808-16. PMID: [15385235](//www.ncbi.nlm.nih.gov/pubmed/15385235).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15385235/citedby/) Fields:

Acq Acquired Immunodeficiency Synd

Translation:Humans

  48. Hong J, Zang YC, **Hutton G** , [Rivera VM](https://profiles.viictr.org/profile/268173), Zhang JZ. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. J Neuroimmunol. 2004 Jul; 152(1-2):126-39. PMID: [15223245](//www.ncbi.nlm.nih.gov/pubmed/15223245).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15223245/citedby/) Fields:

All Allergy and ImmunologyNeu Neurology

Translation:HumansCells

  49. Sun W, [Popat U](https://profiles.viictr.org/profile/12583693), **Hutton G** , Zang YC, [Krance R](https://profiles.viictr.org/profile/268199), [Carrum G](https://profiles.viictr.org/profile/269657), Land GA, [Heslop H](https://profiles.viictr.org/profile/269811), [Brenner M](https://profiles.viictr.org/profile/268200), Zhang JZ. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain. 2004 May; 127(Pt 5):996-1008. PMID: [14985264](//www.ncbi.nlm.nih.gov/pubmed/14985264).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14985264/citedby/) Fields:

Bra BrainNeu Neurology

Translation:HumansCells

  50. Zhang J, **Hutton G** , Zang Y. A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis. Clin Ther. 2002 Dec; 24(12):1998-2021. PMID: [12581542](//www.ncbi.nlm.nih.gov/pubmed/12581542).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12581542/citedby/) Fields:

Dru Drug TherapyThe Therapeutics

Translation:HumansAnimalsCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 50 publications over 19 distinct years, with a maximum of
7 publications in 2020 and
2021](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|7&cht=bvs&chd=t:0,0,0,0,0,0,0,0,14,0,71,14,0,29,57,14,29,43,0,14,0,29,14,14,14,29,100,100,57,43,29&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2002| 1  
2004| 5  
2005| 1  
2007| 2  
2008| 4  
2009| 1  
2010| 2  
2011| 3  
2013| 1  
2015| 2  
2016| 1  
2017| 1  
2018| 1  
2019| 2  
2020| 7  
2021| 7  
2022| 4  
2023| 3  
2024| 2  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

HUTTON's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (194)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Multiple Sclerosis](https://profiles.viictr.org/profile/255794)
  * [Multiple Sclerosis, Relapsing-Remitting](https://profiles.viictr.org/profile/247016)
  * [Meningoencephalitis](https://profiles.viictr.org/profile/246691)
  * [Meningitis, Cryptococcal](https://profiles.viictr.org/profile/251355)
  * [Immune Reconstitution Inflammatory Syndrome](https://profiles.viictr.org/profile/258472)

[Explore](https://profiles.viictr.org/profile/267030/198)

_

Co-Authors (21)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [CUASCUT, FERNANDO](https://profiles.viictr.org/profile/24845174)
  * [APARASU, RAJENDER](https://profiles.viictr.org/profile/268977)
  * [PEREZ, CARLOS](https://profiles.viictr.org/profile/35089812)
  * [FISHER, KRISTEN](https://profiles.viictr.org/profile/37935574)
  * [MANDEL, JACOB](https://profiles.viictr.org/profile/8183294)

[Explore](https://profiles.viictr.org/profile/267030/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [RIVERA, VICTOR](https://profiles.viictr.org/profile/268173)
  * [KHAVARI, ROSE](https://profiles.viictr.org/profile/9909039)
  * [APARASU, RAJENDER](https://profiles.viictr.org/profile/268977)
  * [LOTZE, TIMOTHY](https://profiles.viictr.org/profile/267050)
  * [WEINER, HOWARD](https://profiles.viictr.org/profile/17062693)

[Explore](https://profiles.viictr.org/profile/267030/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [CRUZ-LAUREANO, DANIEL](https://profiles.viictr.org/profile/43590486)
  * [ECHIVERRI, KARL](https://profiles.viictr.org/profile/38374058)
  * [KAPADIA, AVNI](https://profiles.viictr.org/profile/41450431)
  * [KASS, JOSEPH](https://profiles.viictr.org/profile/267072)
  * [YU, MELISSA](https://profiles.viictr.org/profile/270063)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [CHERIAN, VENEETHA](https://profiles.viictr.org/profile/268869)
  * [DAMANI, RAHUL](https://profiles.viictr.org/profile/3009575)
  * [DOODY, RACHELLE](https://profiles.viictr.org/profile/269523)
  * [LEE, TOM](https://profiles.viictr.org/profile/3010104)
  * [SARWAR, ALIYA](https://profiles.viictr.org/profile/269394)

_

